title: Comment on Fabrizi et al.: Treatment of hepatitis C after kidney transplant: A pooled analysis of observational studies.
authors.affiliation: Shenzhen Polytechnic, Shenzhen, 518055, China.
authors.forename: Yan-na
authors.initials: YN
authors.lastname: Pan
authors.affiliation: Zhujiang Hospital of Southern Medical University, Guangzhou, 510282, China.
authors.forename: Ya-jun
authors.initials: YJ
authors.lastname: Luo
authors.affiliation: Shenzhen Polytechnic, Shenzhen, 518055, China.
authors.forename: Shuai
authors.initials: S
authors.lastname: He
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D066027:Transplant Recipients
chemical_list: D000998:Antiviral Agents; D007372:Interferons